BRISTOL-MYERS SQUIBB COMPANY Income Tax Expense
BRISTOL-MYERS SQUIBB COMPANY (BMY) reported Income Tax Expense of $770.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-30
- BRISTOL-MYERS SQUIBB COMPANY income tax expense (benefit) for the quarter ending 2026-06-30 was $770.00M, a 67.39% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY income tax expense (benefit) for the quarter ending 2026-03-31 was $561.00M, a 10.22% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY income tax expense (benefit) for the quarter ending 2025-12-31 was $384.00M, a 287.88% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY income tax expense (benefit) for the quarter ending 2025-09-30 was $919.00M, a 99.35% increase year-over-year.
- BRISTOL-MYERS SQUIBB COMPANY income tax expense (benefit) for fiscal 2025 was $2.27B, a 310.11% increase from fiscal 2024.
- BRISTOL-MYERS SQUIBB COMPANY income tax expense (benefit) for fiscal 2024 was $554.00M, a 38.50% increase from fiscal 2023.
- BRISTOL-MYERS SQUIBB COMPANY income tax expense (benefit) for fiscal 2023 was $400.00M, a 70.76% decline from fiscal 2022.
- BRISTOL-MYERS SQUIBB COMPANY income tax expense (benefit) for fiscal 2022 was $1.37B, a 26.20% increase from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $770.00M 10-Q · filed 2026-07-30 | $1.33B 10-Q · filed 2026-07-30 | $1.72B derived: sum of 3 quarters · filed 2026-07-30 | $2.63B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2026-03-31 | $561.00M 10-Q · filed 2026-04-30 | $945.00M derived: sum of 2 quarters · filed 2026-04-30 | $1.86B derived: sum of 3 quarters · filed 2026-04-30 | $2.32B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-12-31 | $384.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $1.30B derived: sum of 2 quarters · filed 2026-02-11 | $1.76B derived: sum of 3 quarters · filed 2026-07-30 | $2.27B 10-K · filed 2026-02-11 | |||
| 2025-09-30 | $919.00M 10-Q · filed 2025-10-30 | $1.38B derived: sum of 2 quarters · filed 2026-07-30 | $1.89B 10-Q · filed 2025-10-30 | $1.99B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-06-30 | $460.00M 10-Q · filed 2026-07-30 | $969.00M 10-Q · filed 2026-07-30 | $1.07B derived: sum of 3 quarters · filed 2026-07-30 | $1.53B derived: sum of 4 quarters · filed 2026-07-30 | |||
| 2025-03-31 | $509.00M 10-Q · filed 2026-04-30 | $608.00M derived: sum of 2 quarters · filed 2026-04-30 | $1.07B derived: sum of 3 quarters · filed 2026-04-30 | $671.00M derived: sum of 4 quarters · filed 2026-04-30 | |||
| 2024-12-31 | $99.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $560.00M derived: sum of 2 quarters · filed 2026-02-11 | $162.00M derived: sum of 3 quarters · filed 2026-02-11 | $554.00M 10-K · filed 2026-02-11 | |||
| 2024-09-30 | $461.00M 10-Q · filed 2025-10-30 | $63.00M derived: sum of 2 quarters · filed 2025-10-30 | $455.00M 10-Q · filed 2025-10-30 | $367.00M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-06-30 | -$398.00M 10-Q · filed 2025-07-31 | -$6.00M 10-Q · filed 2025-07-31 | -$94.00M derived: sum of 3 quarters · filed 2026-02-11 | $109.00M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2024-03-31 | $392.00M 10-Q · filed 2025-04-24 | $304.00M derived: sum of 2 quarters · filed 2026-02-11 | $507.00M derived: sum of 3 quarters · filed 2026-02-11 | $289.00M derived: sum of 4 quarters · filed 2026-02-11 | |||
| 2023-12-31 | -$88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $115.00M derived: sum of 2 quarters · filed 2026-02-11 | -$103.00M derived: sum of 3 quarters · filed 2026-02-11 | $400.00M 10-K · filed 2026-02-11 | |||
| 2023-09-30 | $203.00M 10-Q · filed 2024-10-31 | -$15.00M derived: sum of 2 quarters · filed 2024-10-31 | $488.00M 10-Q · filed 2024-10-31 | $322.00M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-06-30 | -$218.00M 10-Q · filed 2024-07-26 | $285.00M 10-Q · filed 2024-07-26 | $119.00M derived: sum of 3 quarters · filed 2025-02-12 | $720.00M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2023-03-31 | $503.00M 10-Q · filed 2024-04-25 | $337.00M derived: sum of 2 quarters · filed 2025-02-12 | $938.00M derived: sum of 3 quarters · filed 2025-02-12 | $1.47B derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2022-12-31 | -$166.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $435.00M derived: sum of 2 quarters · filed 2025-02-12 | $964.00M derived: sum of 3 quarters · filed 2025-02-12 | $1.37B 10-K · filed 2025-02-12 | |||
| 2022-09-30 | $601.00M 10-Q · filed 2023-10-26 | $1.13B derived: sum of 2 quarters · filed 2023-10-26 | $1.53B 10-Q · filed 2023-10-26 | $1.02B derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2022-06-30 | $529.00M 10-Q · filed 2023-07-27 | $933.00M 10-Q · filed 2023-07-27 | $419.00M derived: sum of 3 quarters · filed 2024-02-13 | $1.02B derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2022-03-31 | $404.00M 10-Q · filed 2023-04-27 | -$110.00M derived: sum of 2 quarters · filed 2024-02-13 | $495.00M derived: sum of 3 quarters · filed 2024-02-13 | $987.00M derived: sum of 4 quarters · filed 2024-02-13 | |||
| 2021-12-31 | -$514.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | $91.00M derived: sum of 2 quarters · filed 2024-02-13 | $583.00M derived: sum of 3 quarters · filed 2024-02-13 | $1.08B 10-K · filed 2024-02-13 | |||
| 2021-09-30 | $605.00M 10-Q · filed 2022-10-26 | $1.10B derived: sum of 2 quarters · filed 2022-10-26 | $1.60B 10-Q · filed 2022-10-26 | $1.17B derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-06-30 | $492.00M 10-Q · filed 2022-07-27 | $993.00M 10-Q · filed 2022-07-27 | $569.00M derived: sum of 3 quarters · filed 2023-02-14 | $948.00M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-03-31 | $501.00M 10-Q · filed 2022-04-29 | $77.00M derived: sum of 2 quarters · filed 2023-02-14 | $456.00M derived: sum of 3 quarters · filed 2023-02-14 | $2.16B derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2020-12-31 | -$424.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$45.00M derived: sum of 2 quarters · filed 2023-02-14 | $1.66B derived: sum of 3 quarters · filed 2023-02-14 | $2.12B 10-K · filed 2023-02-14 | |||
| 2020-09-30 | $379.00M 10-Q · filed 2021-10-27 | $2.09B derived: sum of 2 quarters · filed 2021-10-27 | $2.55B 10-Q · filed 2021-10-27 | $3.48B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-06-30 | $1.71B 10-Q · filed 2021-07-28 | $2.17B 10-Q · filed 2021-07-28 | $3.10B derived: sum of 3 quarters · filed 2022-02-09 | $3.08B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2020-03-31 | $462.00M 10-Q · filed 2021-04-29 | $1.39B derived: sum of 2 quarters · filed 2022-02-09 | $1.38B derived: sum of 3 quarters · filed 2022-02-09 | $1.71B derived: sum of 4 quarters · filed 2022-02-09 | |||
| 2019-12-31 | $931.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-09 | $914.00M derived: sum of 2 quarters · filed 2022-02-09 | $1.25B derived: sum of 3 quarters · filed 2022-02-09 | $1.51B 10-K · filed 2022-02-09 | |||
| 2019-09-30 | -$17.00M 10-Q · filed 2020-11-05 | $320.00M derived: sum of 2 quarters · filed 2020-11-05 | $584.00M 10-Q · filed 2020-11-05 | $931.00M derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-06-30 | $337.00M 10-Q · filed 2020-08-06 | $601.00M 10-Q · filed 2020-08-06 | $948.00M derived: sum of 3 quarters · filed 2021-02-10 | $1.20B derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2019-03-31 | $264.00M 10-Q · filed 2020-05-07 | $611.00M derived: sum of 2 quarters · filed 2021-02-10 | $866.00M derived: sum of 3 quarters · filed 2021-02-10 | $1.00B derived: sum of 4 quarters · filed 2021-02-10 | |||
| 2018-12-31 | $347.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-10 | $602.00M derived: sum of 2 quarters · filed 2021-02-10 | $737.00M derived: sum of 3 quarters · filed 2021-02-10 | $1.02B 10-K · filed 2021-02-10 | |||
| 2018-09-30 | $255.00M 10-Q · filed 2019-10-31 | $390.00M derived: sum of 2 quarters · filed 2019-10-31 | $674.00M 10-Q · filed 2019-10-31 | $3.70B derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $135.00M 10-Q · filed 2019-07-25 | $419.00M 10-Q · filed 2019-07-25 | $3.45B derived: sum of 3 quarters · filed 2020-02-24 | $3.77B derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $284.00M 10-Q · filed 2019-04-25 | $3.31B derived: sum of 2 quarters · filed 2020-02-24 | $3.64B derived: sum of 3 quarters · filed 2020-02-24 | $4.01B derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $3.03B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $3.35B derived: sum of 2 quarters · filed 2020-02-24 | $3.73B derived: sum of 3 quarters · filed 2020-02-24 | $4.16B 10-K · filed 2020-02-24 | |||
| 2017-09-30 | $327.00M 10-Q · filed 2018-10-25 | $700.00M derived: sum of 2 quarters · filed 2018-10-25 | $1.13B 10-Q · filed 2018-10-25 | $1.32B derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2017-06-30 | $373.00M 10-Q · filed 2018-07-26 | $802.00M 10-Q · filed 2018-07-26 | $990.00M derived: sum of 3 quarters · filed 2019-02-25 | $1.33B derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2017-03-31 | $429.00M 10-Q · filed 2018-04-26 | $617.00M derived: sum of 2 quarters · filed 2019-02-25 | $961.00M derived: sum of 3 quarters · filed 2019-02-25 | $1.39B derived: sum of 4 quarters · filed 2019-02-25 | |||
| 2016-12-31 | $188.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $532.00M derived: sum of 2 quarters · filed 2019-02-25 | $959.00M derived: sum of 3 quarters · filed 2019-02-25 | $1.41B 10-K · filed 2019-02-25 | |||
| 2016-09-30 | $344.00M 10-Q · filed 2017-10-26 | $771.00M derived: sum of 2 quarters · filed 2017-10-26 | $1.22B 10-Q · filed 2017-10-26 | $998.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-06-30 | $427.00M 10-Q · filed 2017-07-27 | $876.00M 10-Q · filed 2017-07-27 | $654.00M derived: sum of 3 quarters · filed 2018-02-13 | $911.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2016-03-31 | $449.00M 10-Q · filed 2017-04-27 | $227.00M derived: sum of 2 quarters · filed 2018-02-13 | $484.00M derived: sum of 3 quarters · filed 2018-02-13 | $646.00M derived: sum of 4 quarters · filed 2018-02-13 | |||
| 2015-12-31 | -$222.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | $35.00M derived: sum of 2 quarters · filed 2018-02-13 | $197.00M derived: sum of 3 quarters · filed 2018-02-13 | $446.00M 10-K · filed 2018-02-13 | |||
| 2015-09-30 | $257.00M 10-Q · filed 2016-10-27 | $419.00M derived: sum of 2 quarters · filed 2016-10-27 | $668.00M 10-Q · filed 2016-10-27 | $581.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-06-30 | $162.00M 10-Q · filed 2016-07-28 | $411.00M 10-Q · filed 2016-07-28 | $324.00M derived: sum of 3 quarters · filed 2017-02-21 | $600.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2015-03-31 | $249.00M 10-Q · filed 2016-04-28 | $162.00M derived: sum of 2 quarters · filed 2017-02-21 | $438.00M derived: sum of 3 quarters · filed 2017-02-21 | $552.00M derived: sum of 4 quarters · filed 2017-02-21 | |||
| 2014-12-31 | -$87.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21 | $189.00M derived: sum of 2 quarters · filed 2017-02-21 | $303.00M derived: sum of 3 quarters · filed 2017-02-21 | $352.00M 10-K · filed 2017-02-21 | |||
| 2014-09-30 | $276.00M 10-Q · filed 2015-10-27 | $390.00M derived: sum of 2 quarters · filed 2015-10-27 | $439.00M 10-Q · filed 2015-10-27 | $573.00M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-06-30 | $114.00M 10-Q · filed 2015-07-23 | $163.00M 10-Q · filed 2015-07-23 | $297.00M derived: sum of 3 quarters · filed 2016-02-12 | $423.00M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2014-03-31 | $49.00M 10-Q · filed 2015-04-28 | $183.00M derived: sum of 2 quarters · filed 2016-02-12 | $309.00M derived: sum of 3 quarters · filed 2016-02-12 | $309.00M derived: sum of 4 quarters · filed 2016-02-12 | |||
| 2013-12-31 | $134.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $260.00M derived: sum of 2 quarters · filed 2016-02-12 | $260.00M derived: sum of 3 quarters · filed 2016-02-12 | $311.00M 10-K · filed 2016-02-12 | |||
| 2013-09-30 | $126.00M 10-Q · filed 2014-10-24 | $126.00M derived: sum of 2 quarters · filed 2014-10-24 | $177.00M 10-Q · filed 2014-10-24 | -$234.00M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | $51.00M 10-Q · filed 2014-07-24 | -$360.00M derived: sum of 3 quarters · filed 2015-02-13 | -$906.00M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2013-03-31 | $51.00M 10-Q · filed 2014-04-29 | -$360.00M derived: sum of 2 quarters · filed 2015-02-13 | -$906.00M derived: sum of 3 quarters · filed 2015-02-13 | -$655.00M derived: sum of 4 quarters · filed 2015-02-13 | |||
| 2012-12-31 | -$411.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$957.00M derived: sum of 2 quarters · filed 2015-02-13 | -$706.00M derived: sum of 3 quarters · filed 2015-02-13 | -$161.00M 10-K · filed 2015-02-13 | |||
| 2012-09-30 | -$546.00M 10-Q · filed 2013-10-23 | -$295.00M derived: sum of 2 quarters · filed 2013-10-23 | $250.00M 10-Q · filed 2013-10-23 | $613.00M derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-06-30 | $251.00M 10-Q · filed 2013-07-25 | $796.00M 10-Q · filed 2013-07-25 | $1.16B derived: sum of 3 quarters · filed 2014-02-14 | $1.63B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2012-03-31 | $545.00M 10-Q · filed 2013-04-25 | $908.00M derived: sum of 2 quarters · filed 2014-02-14 | $1.38B derived: sum of 3 quarters · filed 2014-02-14 | $1.87B derived: sum of 4 quarters · filed 2014-02-14 | |||
| 2011-12-31 | $363.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-14 | $838.00M derived: sum of 2 quarters · filed 2014-02-14 | $1.32B derived: sum of 3 quarters · filed 2014-02-14 | $1.72B 10-K · filed 2014-02-14 | |||
| 2011-09-30 | $475.00M 10-Q · filed 2012-10-24 | $958.00M derived: sum of 2 quarters · filed 2012-10-24 | $1.36B 10-Q · filed 2012-10-24 | $1.93B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-06-30 | $483.00M 10-Q · filed 2012-07-25 | $883.00M 10-Q · filed 2012-07-25 | $1.45B derived: sum of 3 quarters · filed 2013-02-15 | $1.77B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2011-03-31 | $400.00M 10-Q · filed 2012-04-26 | $971.00M derived: sum of 2 quarters · filed 2013-02-15 | $1.28B derived: sum of 3 quarters · filed 2013-02-15 | $1.61B derived: sum of 4 quarters · filed 2013-02-15 | |||
| 2010-12-31 | $571.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $883.00M derived: sum of 2 quarters · filed 2013-02-15 | $1.21B derived: sum of 3 quarters · filed 2013-02-15 | $1.56B 10-K · filed 2013-02-15 | |||
| 2010-09-30 | $312.00M 10-Q · filed 2011-10-27 | $636.00M derived: sum of 2 quarters · filed 2011-10-27 | $987.00M 10-Q · filed 2011-10-27 | $1.18B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-06-30 | $324.00M 10-Q · filed 2011-07-28 | $675.00M 10-Q · filed 2011-07-28 | $863.00M derived: sum of 3 quarters · filed 2012-02-17 | $1.23B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2010-03-31 | $351.00M 10-Q · filed 2011-04-28 | $539.00M derived: sum of 2 quarters · filed 2012-02-17 | $905.00M derived: sum of 3 quarters · filed 2012-02-17 | $1.26B derived: sum of 4 quarters · filed 2012-02-17 | |||
| 2009-12-31 | $188.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $554.00M derived: sum of 2 quarters · filed 2012-02-17 | $907.00M derived: sum of 3 quarters · filed 2012-02-17 | $1.18B 10-K · filed 2012-02-17 | |||
| 2009-09-30 | $366.00M 10-Q · filed 2010-10-26 | $434.00M 10-Q · filed 2009-10-22 | $719.00M derived: sum of 2 quarters · filed 2010-10-26 | $994.00M 10-Q · filed 2010-10-26 | $1.34B 10-Q · filed 2009-10-22 | $1.19B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-06-30 | $353.00M 10-Q · filed 2010-07-22 | $443.00M 10-Q · filed 2009-07-23 | $628.00M 10-Q · filed 2010-07-22 | $906.00M 10-Q · filed 2009-07-23 | $822.00M derived: sum of 3 quarters · filed 2011-02-18 | $1.13B derived: sum of 4 quarters · filed 2011-02-18 | |
| 2009-03-31 | $275.00M 10-Q · filed 2010-04-29 | $469.00M derived: sum of 2 quarters · filed 2011-02-18 | $777.00M derived: sum of 3 quarters · filed 2011-02-18 | $1.03B derived: sum of 4 quarters · filed 2011-02-18 | |||
| 2008-12-31 | $194.00M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-18 | $502.00M derived: sum of 2 quarters · filed 2011-02-18 | $760.00M derived: sum of 3 quarters · filed 2011-02-18 | $1.09B 10-K · filed 2011-02-18 | |||
| 2008-09-30 | $308.00M 10-Q · filed 2009-10-22 | $566.00M derived: sum of 2 quarters · filed 2009-10-22 | $896.00M 10-Q · filed 2009-10-22 | ||||
| 2008-06-30 | $258.00M 10-Q · filed 2009-07-23 | $588.00M 10-Q · filed 2009-07-23 | |||||
| 2007-12-31 | $471.00M 10-K · filed 2010-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |